Type 1 Diabetes Clinical Trial
Official title:
Implementing a Transition Preparation Intervention for Young Adults With Type 1 Diabetes in an Integrated Healthcare Setting
Verified date | November 2020 |
Source | Virginia Commonwealth University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
Status | Completed |
Enrollment | 62 |
Est. completion date | September 16, 2020 |
Est. primary completion date | September 16, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Both members of the youth/parent dyad must meet all eligibility criteria Young adults - English-speaking - patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU) - between ages 18-22 yrs with a - diagnosis of T1D for >1 year Parents - greater than 18 years of age - provide care to the young adult with T1D - are willing to participate in the intervention Medical providers • provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR Exclusion Criteria: Young adults - significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or - medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes Parents - non-English speaking - psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital of Richmond at Virginia Commonwealth University | Richmond | Virginia |
Lead Sponsor | Collaborator |
---|---|
Virginia Commonwealth University | American Diabetes Association |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in diabetes self-efficacy | Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM) | Baseline to 9 months | |
Other | Change in diabetes quality of life | Participant (young adult) report on the Pediatric Quality of Life Diabetes Module | Baseline to 9 months | |
Other | Change in diabetes family responsibility | Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ) | Baseline to 9 months | |
Other | Change in diabetes family conflict | Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS) | Baseline to 9 months | |
Other | Change in depression | Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD) | Baseline to 9 months | |
Other | Change in young adult diabetes distress | Participant (young adult) report on the Diabetes Distress Scale | Baseline to 9 months | |
Other | Change in parent diabetes distress | Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D | Baseline to 9 months | |
Other | Change in autonomy support | Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire | Baseline to 9 months | |
Other | Change in problem solving | Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire | Baseline to 9 months | |
Primary | Number of sessions attended | Number of study visits (attendance) | 6 months | |
Primary | Number of session views | Number of opened electronic materials (e.g., opened messages in the patient health portal)) | 6 months | |
Primary | Program acceptability - young adult | Young adult report on satisfaction with the program via an exit survey | 9 months | |
Primary | Program acceptability - parent | Parent report on satisfaction with the program via an exit survey | 9 months | |
Primary | Program acceptability - provider | Provider report on satisfaction with the program via an exit survey | 9 months | |
Secondary | Change in Glycemic control | Measurement of hemoglobin A1c (A1c; reported as a percentage) | Baseline to 9 months | |
Secondary | Diabetes-related hospitalizations | Participant report and medical record review of count of reported diabetes-related hospitalizations and complications | 9 months | |
Secondary | Change in adherence to diabetes care regimen | Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ) | Baseline to 9 months | |
Secondary | Change in transition readiness | Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ) | Baseline to 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02855307 -
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT02914886 -
Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
|
Phase 4 |